Author | Lynda Charters

Articles

Subretinal gene therapy safe with visual benefit

June 18, 2020

Article

This study provided clinical proof of concept for viral vector-mediated gene supplementation therapy of inherited day blindness caused by pathogenic variants in the cone photoreceptor-specific gene CNGA3.

x